Enliven Therapeutics, Inc. (ELVN) SEC filings
ELVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$46.85−0.77 (-1.62%)
Close on Nov 17, 2026Market cap $3.43BP/E –Yield –
SEC filings
40 of Enliven Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2026 | Oct 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2026 | Jun 10, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 9, 2026 | Apr 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2026 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2026 | Jan 7, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2025 | Dec 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 24, 2025 | Apr 28, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2025 | Mar 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2024 | Jun 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |
| Current report | 8-K | May 14, 2024 | May 14, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 18, 2024 | Apr 26, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 11, 2024 | Apr 11, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2024 | Apr 9, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2024 | Mar 19, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 14, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 14, 2024 | Mar 14, 2024 | SEC EDGAR |
See a number that looks wrong?